ZADEC ApS: Financial statements 2024
CVR: 29312206
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ZADEC ApS (CVR 29312206) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -84,988 and a net result of DKK -308,786 compared with DKK -354,620 the year before. Equity in the 2024 report amounted to DKK -2,331,125.
- Gross Profit
- DKK -84,988
- Profit/Loss
- DKK -308,786
- Equity
- DKK -2,331,125
- Total Assets
- DKK 437,318
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -85 t. | -309 t. | -2.3 mio. | - |
| 2023 | - | -150 t. | -355 t. | -2 mio. | - |
| 2022 | - | -205 t. | -249 t. | -1.7 mio. | - |
| 2021 | - | -224 t. | -273 t. | -1.4 mio. | - |
| 2020 | - | -231 t. | -356 t. | -1.1 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ZADEC ApS has published its annual report for 2023. Gross profit came to DKK -150,400, and the net result was DKK -354,620.
About ZADEC ApS
ZADEC ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Trine Ahlgreen. The company is owned by MC2 Therapeutics A/S and FEY HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -115,999 and a net result of DKK -377,192 compared with DKK -308,786 the year before. Equity in the 2025 report amounted to DKK -2,708,317.